Skip to content

Brolucizumab

Published: July 26, 2026Updated: September 3, 2026

Byooviz is a brand-name biosimilar medication containing ranibizumab-nuna, designed to treat certain eye conditions affecting the retina. It is administered as an intravitreal injection into the eye by a healthcare professional and is specifically used for ophthalmologic conditions involving abnormal blood vessel growth and fluid leakage.

Quick summary

Byooviz is an anti-VEGF biosimilar injection used to treat wet age-related macular degeneration and other retinal conditions by inhibiting abnormal blood vessel growth in the eye.

Medically reviewed by WellAlly Editorial TeamLast reviewed September 3, 2026Editorial policy

Key facts at a glance

RxNorm
2602355
Generic
Byooviz
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Byooviz is used to treat neovascular (wet) age-related macular degeneration (AMD), diabetic macular edema, diabetic retinopathy, macular edema following retinal vein occlusion, and myopic choroidal neovascularization.

Byooviz is a biosimilar to Lucentis that works as a vascular endothelial growth factor A (VEGF-A) inhibitor. It binds to VEGF-A, preventing it from interacting with its receptors and thereby reducing abnormal blood vessel growth and decreasing fluid leakage in the retina.

Byooviz is administered as an intravitreal injection by a qualified healthcare professional. Common side effects may include eye redness, pain, floaters, and increased intraocular pressure. Patients should be monitored for serious infections and retinal detachment. As a biosimilar, it is highly similar to the reference product with no clinically meaningful differences in safety or effectiveness.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed September 3, 2026. · Read our editorial policy